Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. scPharmaceuticals
SCPH

Buy scPharmaceuticals (SCPH) Stock

SCPH
See SCPH stock price and Buy/Sell scPharmaceuticals with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
SCPH

scPharmaceuticals (SCPH)

About scPharmaceuticals (SCPH)

scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is...Read more
Market Cap
$146.44M
1 Year High
$7.24
Volume
39.24k
1 Year Low
$3.48
Price to Earnings Ratio
Open
$5.41
Dividend Rate
High
$5.48
Dividend Yield
Low
$5.26

Community

People who own or watch SCPH stock

scPharmaceuticals Stock News

scPharmaceuticals stock rating

What analysts recommend for SCPH stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1.7

scPharmaceuticals price target

What analysts think SCPH will be worth
Low $3.48
High $10.33
Current $5.35
Target $10.33

Events

List of events that could affect SCPH stock.
16May

Earnings data Q1 2022

11Aug

Earnings data Q2 2022

scPharmaceuticals earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.13
-0.26
-0.39
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022

Expected EPS
Q3 2022
-$0.39
Actual EPS
Q3 2022

Buy scPharmaceuticals (SCPH) Stock

SCPH
See SCPH stock price and Buy/Sell scPharmaceuticals with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch SCPH stock
  • Boodro300 avatar
  • RewardRiskAtLeast10x avatar
  • DivineSoul310 avatar
  • cwowens avatar
  • arlie2206 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.